Jake Mcmillon
NPI: 1467814137
Total Payments
$3,942
2024 Payments
$485.89
Companies
28
Transactions
259
Medicare Patients
5,812
Medicare Billing
$365,915
Payment Breakdown by Category
Food & Beverage$3,942 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,942 | 259 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $864.00 | 58 | $0 (2024) |
| Amgen Inc. | $348.50 | 26 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $341.14 | 20 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $290.92 | 19 | $0 (2024) |
| Lilly USA, LLC | $236.64 | 16 | $0 (2024) |
| GlaxoSmithKline, LLC. | $224.89 | 15 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $205.36 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $179.10 | 13 | $0 (2022) |
| ABBVIE INC. | $176.85 | 11 | $0 (2024) |
| PFIZER INC. | $176.73 | 16 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $485.89 | 30 | Novo Nordisk Inc ($89.51) |
| 2023 | $862.08 | 59 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($165.62) |
| 2022 | $872.36 | 57 | Novo Nordisk Inc ($217.00) |
| 2021 | $910.84 | 58 | Novo Nordisk Inc ($197.93) |
| 2020 | $661.35 | 44 | Novo Nordisk Inc ($196.12) |
| 2019 | $149.60 | 11 | AstraZeneca Pharmaceuticals LP ($35.59) |
All Payment Transactions
259 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: Respiratory | ||||||
| 11/13/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: UROLOGY | ||||||
| 10/07/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $16.24 | General |
| Category: Cardiovascular | ||||||
| 10/03/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $13.57 | General |
| Category: NEUROSCIENCE | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Respiratory | ||||||
| 09/16/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $19.82 | General |
| Category: Endocrinology | ||||||
| 09/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.55 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $13.20 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/05/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $15.49 | General |
| Category: NEUROSCIENCE | ||||||
| 08/01/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Diabetes | ||||||
| 07/16/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $19.05 | General |
| Category: Biological | ||||||
| 07/08/2024 | Novo Nordisk Inc | Rybelsus (Drug) | Food and Beverage | In-kind items and services | $20.02 | General |
| Category: Diabetes | ||||||
| 06/17/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.85 | General |
| Category: Respiratory | ||||||
| 06/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $13.18 | General |
| Category: NEUROSCIENCE | ||||||
| 05/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.03 | General |
| Category: Diabetes | ||||||
| 05/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $16.45 | General |
| 05/23/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $15.04 | General |
| Category: UROLOGY | ||||||
| 05/16/2024 | Medtronic, Inc. | INTELLIS ADAPTIVESTIM (Device) | Food and Beverage | In-kind items and services | $14.33 | General |
| Category: Spinal Cord Neurostimulation | ||||||
| 05/06/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Bone Health | ||||||
| 04/15/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $13.72 | General |
| Category: Obesity | ||||||
| 04/01/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: NEUROSCIENCE | ||||||
| 03/26/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $21.82 | General |
| 03/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Diabetes | ||||||
| 03/07/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.22 | General |
| Category: Cardio-renal | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 28 | 1,590 | 3,544 | $304,268 | $126,264 |
| 2022 | 25 | 1,516 | 3,367 | $304,758 | $118,776 |
| 2021 | 29 | 1,279 | 2,380 | $190,518 | $75,080 |
| 2020 | 32 | 1,427 | 2,155 | $136,726 | $45,794 |
Total Patients
5,812
Total Services
11,446
Medicare Billing
$365,915
Procedure Codes
114
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 158 | 1,163 | $145,375 | $66,933 | 46.0% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 116 | 133 | $27,265 | $12,675 | 46.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 101 | 197 | $27,580 | $10,219 | 37.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 124 | 227 | $24,270 | $9,329 | 38.4% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 129 | 153 | $22,270 | $8,983 | 40.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 34 | 34 | $5,025 | $2,284 | 45.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 125 | 253 | $2,606 | $2,125 | 81.6% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 116 | 204 | $8,509 | $2,101 | 24.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 121 | 223 | $7,125 | $1,684 | 23.6% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 37 | 42 | $3,155 | $1,454 | 46.1% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 35 | 80 | $3,190 | $1,298 | 40.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 36 | 101 | $4,821 | $1,052 | 21.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $2,908 | $950.15 | 32.7% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 55 | 65 | $4,170 | $839.68 | 20.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 40 | 49 | $2,045 | $806.54 | 39.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 46 | 75 | $2,757 | $648.72 | 23.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 32 | 32 | $765.00 | $522.88 | 68.4% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 39 | 54 | $2,585 | $514.08 | 19.9% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 40 | 49 | $1,395 | $433.16 | 31.1% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 19 | 19 | $730.00 | $359.48 | 49.2% |
| 83735 | Magnesium level | Office | 2023 | 30 | 38 | $760.00 | $243.09 | 32.0% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 11 | 23 | $917.00 | $230.01 | 25.1% |
| 81000 | Manual urinalysis test with examination using microscope, non-automated | Office | 2023 | 34 | 54 | $1,305 | $212.76 | 16.3% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 18 | 18 | $234.00 | $109.98 | 47.0% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 18 | 18 | $270.00 | $91.44 | 33.9% |
About Jake Mcmillon
Jake Mcmillon is a Student in an Organized Health Care Education/Training Program healthcare provider based in Paragould, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/22/2016. The National Provider Identifier (NPI) number assigned to this provider is 1467814137.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Jake Mcmillon has received a total of $3,942 in payments from pharmaceutical and medical device companies, with $485.89 received in 2024. These payments were reported across 259 transactions from 28 companies. The most common payment nature is "Food and Beverage" ($3,942).
As a Medicare-enrolled provider, Mcmillon has provided services to 5,812 Medicare beneficiaries, totaling 11,446 services with total Medicare billing of $365,915. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Ad
Practice Information
- Specialty Student in an Organized Health Care Education/Training Program
- Other Specialties Family Medicine
- Location Paragould, AR
- Active Since 03/22/2016
- Last Updated 06/17/2019
- Taxonomy Code 390200000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1467814137
Products in Payments
- XIFAXAN (Drug) $341.14
- Ozempic (Drug) $326.50
- TRELEGY ELLIPTA (Drug) $224.89
- NURTEC ODT (Drug) $212.88
- Kerendia (Drug) $205.36
- Saxenda (Drug) $202.39
- XARELTO (Drug) $179.10
- Wegovy (Drug) $162.53
- FARXIGA (Drug) $154.33
- TRINTELLIX (Drug) $152.52
- EVENITY (Biological) $137.96
- ELIQUIS (Drug) $116.83
- Otezla (Drug) $109.81
- Rybelsus (Drug) $102.52
- EMGALITY (Drug) $102.23
- UBRELVY (Drug) $100.47
- BREZTRI (Drug) $79.79
- Xofluza (Drug) $73.42
- Aimovig (Biological) $71.00
- MOUNJARO (Drug) $70.16
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Student in an Organized Health Care Education/Training Program Doctors in Paragould
Tasha Starks, M.d./Mph, M.D./MPH
Student in an Organized Health Care Education/Training Program — Payments: $517.32
Student in an Organized Health Care Education/Training Program $517.32
Claire Brown
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program